Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
LINAC Devices Market Growth From $5.96 Billion In 2026 To $8.48 Billion By 2030 At A CAGR Of 9.2%
The linac devices market size has shown robust expansion in recent years. It is anticipated to increase from $5.48 billion in 2025 to $5.96 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.9%. This past growth can be credited to the expansion of cancer treatment infrastructure, a rise in global cancer incidence, the adoption of advanced radiotherapy techniques, increased availability of oncology specialists, and improvements in radiation delivery accuracy.
The linac devices market is projected to experience substantial expansion over the upcoming years, reaching $8.48 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.2%. This anticipated growth during the forecast period is fueled by factors such as increased capital in precision oncology, a rising need for individualized cancer therapies, developments in AI-powered radiotherapy strategies, broader availability of radiotherapy in developing regions, and the increasing uptake of compact linac systems. Key trends expected during this period involve the greater acceptance of image-guided radiation therapy, a surge in the utilization of high-energy linac systems, wider incorporation of AI-based treatment planning, the proliferation of compact and modular linac designs, and a heightened emphasis on accurate dose delivery.
Get A Free Sample Report With In-Depth Market Insights:
LINAC Devices Market Growth Catalysts And Demand Drivers
The increasing incidence of cancer is projected to fuel the expansion of the LINAC devices market moving forward. Cancer prevalence refers to the total count of individuals, both those newly diagnosed and previously diagnosed, who are currently alive with a history of cancer at a specific moment. This rise in cancer prevalence is attributed to lifestyle-related risks such as poor dietary habits, smoking, alcohol intake, and exposure to environmental pollutants, which heighten the likelihood of developing various cancers. LINAC devices contribute to cancer management by delivering precise, high-energy radiation beams that target tumors while minimizing damage to adjacent healthy tissues. These devices enhance treatment accuracy, improve patient outcomes, and enable advanced radiotherapy techniques for more effective cancer care. For instance, in February 2025, as per Cancer Australia, an Australia-based government agency, there were 4,641 new pancreatic cancer cases in 2024, with 2,414 in males and 2,227 in females. Thus, the escalating prevalence of cancer is propelling the LINAC devices market.
LINAC Devices Market Segment Analysis: What Are The Core Market Categories?
The linac devices market covered in this report is segmented –
1) By Product: High Energy, Medium Energy
2) By Application: Breast Cancer, Colorectal Cancer, Head And Neck Cancer, Lung Cancer, Prostate Cancer, Other Applications
3) By End User: Clinics, Hospitals
Subsegments:
1) By High Energy: Linear Accelerators For Radiation Therapy, Electron LINACs, Photon LINACs
2) By Medium Energy: Medium Energy Photon LINACs, Compact LINAC Systems
LINAC Devices Market Trends Shaping Long-Term Demand
Leading companies in the LINAC devices market are launching products that utilize innovative technologies, such as the ViewRay MRIdian MRI-Guided Radiation Therapy System, to maintain their market presence. For example, in March 2023, GenesisCare Pty Ltd., a US-based provider of cancer and cardiac care, unveiled an MRI-guided radiation therapy system at the Lee Health Regional Cancer Center. The MRIdian system improves treatment by merging precise radiation therapy with advanced, high-resolution MRI guidance, potentially requiring fewer sessions. This product is notable as the first radiotherapy system to incorporate diagnostic-quality MRI with an advanced linear accelerator, also providing access to the MRIdian Stereotactic MRI-guided Adaptive Radiotherapy (SMART) therapy.
LINAC Devices Market Company Landscape And Competitive Strategy
Major companies operating in the linac devices market are Elekta AB, Varian Medical Systems Inc, Siemens Healthineers GmbH, Hitachi Ltd, Mitsubishi Heavy Industries Ltd, Sumitomo Heavy Industries Ltd, Shinva Medical Instrument Co Ltd, Huiheng Medical Inc, IBA SA, Mevion Medical Systems Inc, ViewRay Technologies Inc, Advanced Oncotherapy PLC, RefleXion Medical Inc, ProNova Solutions LLC, Panacea Medical Technologies Pvt Ltd, Best Theratronics Ltd, P-Cure Ltd, Accuray Incorporated, CGN Dasheng Electron Accelerator Technology Co Ltd, Nordion Inc, Theragenics Corporation
View The Full LINAC Devices Market Report:
LINAC Devices Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the LINAC devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global LINAC devices market report during the forecast period. The regions covered in the linac devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.